Compare CODI & CBLL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | CODI | CBLL |
|---|---|---|
| Founded | 2005 | 2014 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Home Furnishings | |
| Sector | Consumer Discretionary | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 869.7M | 726.2M |
| IPO Year | 2005 | 2024 |
| Metric | CODI | CBLL |
|---|---|---|
| Price | $11.45 | $23.73 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 2 | 5 |
| Target Price | $9.25 | ★ $23.20 |
| AVG Volume (30 Days) | ★ 721.8K | 386.4K |
| Earning Date | 05-06-2026 | 05-11-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 56.93 |
| EPS | ★ 0.31 | N/A |
| Revenue | ★ $1,560,757,000.00 | $89,063,000.00 |
| Revenue This Year | N/A | $29.57 |
| Revenue Next Year | $5.25 | $28.44 |
| P/E Ratio | $36.29 | ★ N/A |
| Revenue Growth | 7.62 | ★ 36.09 |
| 52 Week Low | $4.58 | $10.85 |
| 52 Week High | $13.25 | $25.33 |
| Indicator | CODI | CBLL |
|---|---|---|
| Relative Strength Index (RSI) | 53.81 | 64.79 |
| Support Level | $9.86 | $16.70 |
| Resistance Level | $11.85 | $24.64 |
| Average True Range (ATR) | 0.56 | 1.01 |
| MACD | -0.09 | -0.03 |
| Stochastic Oscillator | 13.00 | 71.26 |
Compass Diversified Holdings is a diversified business conglomerate based in the United States having two groups: branded consumer business and industrial business. Branded consumer businesses are characterized as those businesses that capitalize on a valuable brand name in their respective market sector. It includes 5.11, Ergobaby, Liberty Safe, and Velocity Outdoor. Industrial businesses are characterized as those businesses that focus on manufacturing and selling particular products and industrial services within a specific market sector. The company has operations in the United States, Canada, Europe, Asia Pacific, and other International areas.
CeriBell Inc is a medical technology company focused on transforming the diagnosis and management of patients with serious neurological conditions. The company has developed the Ceribell System, a novel, point-of-care electroencephalography (EEG) platform designed to address the unmet needs of patients in the acute care setting. By combining proprietary, portable, and rapidly deployable hardware with sophisticated artificial intelligence (AI)-powered algorithms, the Ceribell System enables rapid diagnosis and continuous monitoring of patients with neurological conditions. Its products are Point-of-Care EEG, Clarity, and EEG Portal.